NVDA
NVIDIA
-- 113.760 TSLA
Tesla
-- 272.060 GME
GameStop
-- 28.360 PLTR
Palantir
-- 92.280 AMD
Advanced Micro Devices
-- 110.190 
🔔 FDA PDUFA Update…
📣 3 PDUFAs left in April! See summary 👇
🗓️ Last week’s PDUFAs:
$Pfizer (PFE.US)$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Pfizer (PFE.US)$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Day One Biopharmaceuticals (DAWN.US)$ : Approved 4/23 🎉
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
$ImmunityBio (IBRX.US)$ : Approved 4/22 🎉
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
$Abeona Therapeutics (ABEO.US)$ : CRL 4/22 🙁
⚠ needs add'l CMC info
⇨ Prademagene zamikeracel (pz-cel)
▹ recessive dystrophic epidermolysis bullosa
▹ BLA
▹ PDUFA date: 5/25/24
⚠ needs add'l CMC info
⇨ Prademagene zamikeracel (pz-cel)
▹ recessive dystrophic epidermolysis bullosa
▹ BLA
▹ PDUFA date: 5/25/24
🚨 This week’s PDUFAs:
$X4 Pharmaceuticals (XFOR.US)$ : Approved 4/29 🎉
⇨ XOLREMDI (mavorixafor)
▹ WHIM syndrome
▹ NDA
▹ PDUFA date: 4/30/24
$X4 Pharmaceuticals (XFOR.US)$ : Approved 4/29 🎉
⇨ XOLREMDI (mavorixafor)
▹ WHIM syndrome
▹ NDA
▹ PDUFA date: 4/30/24
$Aquestive Therapeutics (AQST.US)$ : Approved 4/29 🎉
⇨ Libervant™ (Diazepam) Buccal Film
▹ Seizure clusters (ages 2-5)
▹ NDA
▹ PDUFA date: 4/28/24
⇨ Libervant™ (Diazepam) Buccal Film
▹ Seizure clusters (ages 2-5)
▹ NDA
▹ PDUFA date: 4/28/24
$Neurocrine Biosciences (NBIX.US)$ : 🤔
⇨ INGREZZA
▹ tardive dyskinesia and Huntington's disease related chorea
▹ sNDA
▹ PDUFA date: 4/30/24
⇨ INGREZZA
▹ tardive dyskinesia and Huntington's disease related chorea
▹ sNDA
▹ PDUFA date: 4/30/24
$Liquidia (LQDA.US)$ : 🤔
⇨ YUTREPIA
▹ pulmonary hypertension associated w/ interstitial lung disease
▹ NDA
▹ PDUFA date: April 2024 (est.)
⇨ YUTREPIA
▹ pulmonary hypertension associated w/ interstitial lung disease
▹ NDA
▹ PDUFA date: April 2024 (est.)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
J L 7 2 : Why are stocks still in a soft position and unable to improve
73125363 J L 7 2 : Let's recharge
Master Corgi : Your pic gained you many followers
Vijay Raja : BEQVEZ has the same problem that Roctavian has. Payers have not been sorted . Very slow uptake.